Seeing Is Believing
with an average price target of $7.27. This is a potential upside of $7.27 (0%) from yesterday's end of day stock price of $0.
Acceleron Pharma's activity chart (see below) currently has 175 price targets and 112 ratings on display.
Analysts average stock forecasts to be materialized ratio is 84.36% with an average time for these price targets to be met of 190.06 days.
Most recent stock forecast was given by AKASH TEWARI from JEFFERIES on 08-Oct-2021. First documented stock forecast 14-Aug-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$180
$1.25 (0.70%)
$180
3 years 5 months 3 days ago
(08-Oct-2021)
0/4 (0%)
$34.21 (26.40%)
Hold
$180
3 years 5 months 5 days ago
(05-Oct-2021)
16/17 (94.12%)
$7.9 (4.59%)
257
Hold
$180
$1.25 (0.70%)
$168
3 years 5 months 9 days ago
(01-Oct-2021)
14/15 (93.33%)
$5.65 (3.24%)
303
Hold
$180
$1.25 (0.70%)
3 years 5 months 9 days ago
(01-Oct-2021)
4/5 (80%)
$5.65 (3.24%)
133
Hold
$180
$1.25 (0.70%)
$146
3 years 5 months 9 days ago
(01-Oct-2021)
7/8 (87.5%)
$5.65 (3.24%)
119
What is XLRN (Acceleron Pharma) average time for price targets to be met?
Which analyst has the current highest performing score on XLRN (Acceleron Pharma) with a proven track record?
Which analyst has the most public recommendations on XLRN (Acceleron Pharma)?
Which analyst is the currently most bullish on XLRN (Acceleron Pharma)?
Which analyst is the currently most reserved on XLRN (Acceleron Pharma)?